Department of Neurological Surgery,
Weill Institute for Neurosciences.
J Neurosci. 2020 Mar 11;40(11):2215-2227. doi: 10.1523/JNEUROSCI.1063-19.2019. Epub 2020 Jan 27.
Manipulations that enhance GABAergic inhibition have been associated with improved behavioral phenotypes in autism models, suggesting that autism may be treated by correcting underlying deficits of inhibition. Interneuron transplantation is a method for increasing recipient synaptic inhibition, and it has been considered a prospective therapy for conditions marked by deficient inhibition, including neuropsychiatric disorders. It is unknown, however, whether interneuron transplantation may be therapeutically effective only for conditions marked by reduced inhibition, and it is also unclear whether transplantation improves behavioral phenotypes solely by normalizing underlying circuit defects. To address these questions, we studied the effects of interneuron transplantation in male and female mice lacking the autism-associated gene, , in GABAergic interneurons. mutant mice exhibit social behavior deficits, elevated synaptic inhibition in prefrontal cortex, abnormal baseline and social interaction-evoked electroencephalogram (EEG) signals, and an altered composition of cortical interneuron subtypes. Transplantation of wild-type embryonic interneurons from the medial ganglionic eminence into the prefrontal cortex of neonatal mutants rescued social behavior despite exacerbating excessive levels of synaptic inhibition. Furthermore, transplantation did not normalize recipient EEG signals measured during baseline states. Interneuron transplantation can thus correct behavioral deficits even when those deficits are associated with elevated synaptic inhibition. Moreover, transplantation does not exert therapeutic effects solely by restoring wild-type circuit states. Our findings indicate that interneuron transplantation could offer a novel cell-based approach to autism treatment while challenging assumptions that effective therapies must reverse underlying circuit defects. Imbalances between neural excitation and inhibition are hypothesized to contribute to the pathophysiology of autism. Interneuron transplantation is a method for altering recipient inhibition, and it has been considered a prospective therapy for neuropsychiatric disorders, including autism. Here we examined the behavioral and physiological effects of interneuron transplantation in a mouse genetic model of autism. They demonstrate that transplantation rescues recipient social interaction deficits without correcting a common measure of recipient inhibition, or circuit-level physiological measures. These findings demonstrate that interneuron transplantation can exert therapeutic behavioral effects without necessarily restoring wild-type circuit states, while highlighting the potential of interneuron transplantation as an autism therapy.
增强 GABA 能抑制的操作与自闭症模型中改善的行为表型有关,这表明通过纠正抑制的根本缺陷,自闭症可能得到治疗。中间神经元移植是一种增加受者突触抑制的方法,并且它已被认为是一种用于受抑制不足的疾病的有前途的治疗方法,包括神经精神疾病。然而,尚不清楚中间神经元移植是否仅对受抑制减少的疾病具有治疗效果,也不清楚移植是否仅通过使潜在的电路缺陷正常化来改善行为表型。为了解决这些问题,我们研究了中间神经元移植对缺乏自闭症相关基因 的雄性和雌性小鼠的影响,该基因在 GABA 能中间神经元中表达。 突变小鼠表现出社交行为缺陷、前额叶皮层突触抑制升高、基线和社交互动诱发的脑电图 (EEG) 信号异常以及皮质中间神经元亚型组成改变。将来自内侧神经节隆起的野生型胚胎中间神经元移植到新生 突变体的前额叶皮层中,尽管加重了过度的突触抑制,但挽救了社交行为。此外,移植并没有使基线状态下测量的受者 EEG 信号正常化。因此,即使中间神经元移植与升高的突触抑制相关,也可以纠正行为缺陷。而且,移植不会仅通过恢复野生型电路状态来发挥治疗作用。我们的研究结果表明,尽管中间神经元移植不能纠正所有的电路缺陷,但它仍然可以为自闭症的治疗提供一种新的基于细胞的方法,这挑战了有效治疗必须纠正潜在电路缺陷的假设。神经兴奋与抑制之间的不平衡被假设为导致自闭症的病理生理学的原因。中间神经元移植是一种改变受者抑制的方法,并且已被认为是一种用于神经精神疾病的有前途的治疗方法,包括自闭症。在这里,我们检查了自闭症小鼠遗传模型中中间神经元移植的行为和生理影响。他们表明,移植挽救了受者的社交互动缺陷,而没有纠正受者抑制的常见测量值或电路水平的生理测量值。这些发现表明,中间神经元移植可以发挥治疗行为的作用,而不必恢复野生型电路状态,同时突出了中间神经元移植作为自闭症治疗方法的潜力。